<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(8)</volume><submitter>Lee SH</submitter><pubmed_abstract>In this study, we examined whether aortic contraction, induced by the alpha-2 adrenoceptor agonist dexmedetomidine, is involved in the transactivation of the epidermal growth factor receptor (EGFR) in isolated endothelium-denuded rat aortas. Additionally, we aimed to elucidate the associated underlying cellular mechanisms. The effects of the alpha-2 adrenoceptor inhibitor rauwolscine, EGFR tyrosine kinase inhibitor AG1478, Src kinase inhibitors PP1 and PP2, and matrix metalloproteinase inhibitor GM6001 on EGFR tyrosine phosphorylation and c-Jun NH2-terminal kinase (JNK) phosphorylation induced by dexmedetomidine in rat aortic smooth muscles were examined. In addition, the effects of these inhibitors on dexmedetomidine-induced contraction in isolated endothelium-denuded rat aorta were exami</pubmed_abstract><journal>International journal of molecular sciences</journal><pagination>4320</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9024600</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dexmedetomidine-Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats.</pubmed_title><pmcid>PMC9024600</pmcid><pubmed_authors>Park KE</pubmed_authors><pubmed_authors>Ok SH</pubmed_authors><pubmed_authors>Sohn JT</pubmed_authors><pubmed_authors>Bae SI</pubmed_authors><pubmed_authors>Kim JY</pubmed_authors><pubmed_authors>Lee SH</pubmed_authors><pubmed_authors>Kwon SC</pubmed_authors><pubmed_authors>Ahn SH</pubmed_authors><pubmed_authors>Kim M</pubmed_authors><pubmed_authors>Hwang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dexmedetomidine-Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats.</name><description>In this study, we examined whether aortic contraction, induced by the alpha-2 adrenoceptor agonist dexmedetomidine, is involved in the transactivation of the epidermal growth factor receptor (EGFR) in isolated endothelium-denuded rat aortas. Additionally, we aimed to elucidate the associated underlying cellular mechanisms. The effects of the alpha-2 adrenoceptor inhibitor rauwolscine, EGFR tyrosine kinase inhibitor AG1478, Src kinase inhibitors PP1 and PP2, and matrix metalloproteinase inhibitor GM6001 on EGFR tyrosine phosphorylation and c-Jun NH2-terminal kinase (JNK) phosphorylation induced by dexmedetomidine in rat aortic smooth muscles were examined. In addition, the effects of these inhibitors on dexmedetomidine-induced contraction in isolated endothelium-denuded rat aorta were exami</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-19T13:02:09.929Z</modification><creation>2025-04-19T13:02:09.929Z</creation></dates><accession>S-EPMC9024600</accession><cross_references><pubmed>35457136</pubmed><doi>10.3390/ijms23084320</doi></cross_references></HashMap>